NCBIO: Part D drug price ‘negotiation’ comes at cost of jobs, investment, cures
A recent analysis of the legislation passed by the Senate determined that it will likely lead to the loss of over 590,000 jobs across the country. In North Carolina, the toll would be a direct biopharma job loss of almost 6,600 jobs, along with nearly 37,000 jobs supported by the life sciences industry.
Read More